Search research articles
Contact Us
Filters
Showing results (51-60 of 119) with videos related to
Page
of 12
Sort By:
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG
|
June 23, 2017
Predictors of Adverse Outcomes in Children With Staphylococcus aureus Bacteremia
Ganesh Kumarachandran, Jennifer Kristie Johnson, Debbie-Ann Shirley, et al.
AIDS Research and Treatment
|
April 15, 2011
Incidence of Severe Hepatotoxicity Related to Antiretroviral Therapy in HIV/HCV Coinfected Patients
Emily L Heil, Mary L Townsend, Kenneth Shipp, et al.
Open Forum Infectious Diseases
|
November 2, 2020
Management of Gram-Negative Bloodstream Infections in the Era of Rapid Diagnostic Testing: Impact With and Without Antibiotic Stewardship
Kimberly C Claeys, Emily L Heil, Stephanie Hitchcock, et al.
Diagnostic Microbiology and Infectious Disease
|
August 2, 2021
The potential impact of discrepancies between automated susceptibility platforms and other testing metho`dologies for cefazolin in the treatment of Enterobacterales bloodstream infections
Mandee Noval, Emily L Heil, Paula Williams, et al.
Open Forum Infectious Diseases
|
June 22, 2026
Recalibration and Validation of a Risk Scoring Tool to Predict Multidrug-Resistant <i>Pseudomonas aeruginosa</i>
Nhu Le, Hyunuk Seung, Megan E Dunning, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 20, 2025
The Effectiveness of Newer Beta-Lactams for the Treatment of Antimicrobial-Resistant Gram-Negative Meningitis
Alice J Hsu, Kathleen Chiotos, Emily L Heil, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 17, 2023
Delabeling for the duration? β-Lactam prescribing in hospitalized patients after penicillin skin testing
Christopher M Bland, Emily L Heil, Ashley Asbell, et al.
Open Forum Infectious Diseases
|
July 25, 2022
Real-world Antimicrobial Stewardship Experience in a Large Academic Medical Center: Using Statistical and Machine Learning Approaches to Identify Intervention "Hotspots" in an Antibiotic Audit and Feedback Program
Katherine E Goodman, Emily L Heil, Kimberly C Claeys, et al.
Antiviral Therapy
|
September 8, 2018
Effectiveness of 8 weeks of ledipasvir/sofosbuvir for hepatitis C in HCV-HIV-coinfected patients
Ana D Vega, Lauren M Hynicka, Kimberly Claeys, et al.
Antimicrobial Agents and Chemotherapy
|
July 4, 2018
Pharmacodynamic Target Attainment for Cefepime, Meropenem, and Piperacillin-Tazobactam Using a Pharmacokinetic/Pharmacodynamic-Based Dosing Calculator in Critically Ill Patients
Emily L Heil, David P Nicolau, Andras Farkas, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 119) with videos related to
Sort By:
Page
of 12
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG
|
June 23, 2017
Predictors of Adverse Outcomes in Children With Staphylococcus aureus Bacteremia
Ganesh Kumarachandran, Jennifer Kristie Johnson, Debbie-Ann Shirley, et al.
AIDS Research and Treatment
|
April 15, 2011
Incidence of Severe Hepatotoxicity Related to Antiretroviral Therapy in HIV/HCV Coinfected Patients
Emily L Heil, Mary L Townsend, Kenneth Shipp, et al.
Open Forum Infectious Diseases
|
November 2, 2020
Management of Gram-Negative Bloodstream Infections in the Era of Rapid Diagnostic Testing: Impact With and Without Antibiotic Stewardship
Kimberly C Claeys, Emily L Heil, Stephanie Hitchcock, et al.
Diagnostic Microbiology and Infectious Disease
|
August 2, 2021
The potential impact of discrepancies between automated susceptibility platforms and other testing metho`dologies for cefazolin in the treatment of Enterobacterales bloodstream infections
Mandee Noval, Emily L Heil, Paula Williams, et al.
Open Forum Infectious Diseases
|
June 22, 2026
Recalibration and Validation of a Risk Scoring Tool to Predict Multidrug-Resistant <i>Pseudomonas aeruginosa</i>
Nhu Le, Hyunuk Seung, Megan E Dunning, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 20, 2025
The Effectiveness of Newer Beta-Lactams for the Treatment of Antimicrobial-Resistant Gram-Negative Meningitis
Alice J Hsu, Kathleen Chiotos, Emily L Heil, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 17, 2023
Delabeling for the duration? β-Lactam prescribing in hospitalized patients after penicillin skin testing
Christopher M Bland, Emily L Heil, Ashley Asbell, et al.
Open Forum Infectious Diseases
|
July 25, 2022
Real-world Antimicrobial Stewardship Experience in a Large Academic Medical Center: Using Statistical and Machine Learning Approaches to Identify Intervention "Hotspots" in an Antibiotic Audit and Feedback Program
Katherine E Goodman, Emily L Heil, Kimberly C Claeys, et al.
Antiviral Therapy
|
September 8, 2018
Effectiveness of 8 weeks of ledipasvir/sofosbuvir for hepatitis C in HCV-HIV-coinfected patients
Ana D Vega, Lauren M Hynicka, Kimberly Claeys, et al.
Antimicrobial Agents and Chemotherapy
|
July 4, 2018
Pharmacodynamic Target Attainment for Cefepime, Meropenem, and Piperacillin-Tazobactam Using a Pharmacokinetic/Pharmacodynamic-Based Dosing Calculator in Critically Ill Patients
Emily L Heil, David P Nicolau, Andras Farkas, et al.
Page
of 12